Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2 and Intravitreal Methotrexate in Primary Vitreoretinal Lymphoma
NCT03746223Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in primary vitreoretinal lymphoma (PVRL), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
primary vitreoretinal lymphoma (PVRL)
Beyond the preview
Go deeper on NCT03746223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746223.